Patents by Inventor Philippe Baudu

Philippe Baudu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7534559
    Abstract: Disclosed are plasmids that contain and express in vivo in a feline host cell nucleic acid molecules. The plasmid can include nucleic molecule(s) having sequence(s) encoding infectious peritonitis virus M; feline immunodeficiency virus env, or gag, or pro, or gag and pro, or env and gag and pro; rabies G; or feline leukemia virus env and/or gag. Compositions containing such plasmids, methods of use employing such plasmids, and kits involving such plasmids, are also disclosed.
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: May 19, 2009
    Assignee: Merial
    Inventors: Jean-Christophe Audonnet, Annabelle Bouchardon, Philippe Baudu, Michel Riviere
  • Publication number: 20060024329
    Abstract: Disclosed and claimed is a recombinant canine herpes virus (CHV). The recombinant CHV includes and expresses at least one heterologous nucleotide sequence encoding an antigen. The antigen can be canine distemper virus HA, canine distemper virus F, rabies virus G, canine parvovirus VP2, parainfluenza virus type 2 HA, parainfluenza virus type 2 F, Borrelia burgdorferi OspA, or Borrelia burgdorferi OspB. The at least one heterologous nucleotide sequence can be in at least one insertion site selected from the group consisting of ORF3 (SEQ ID NO:4), ORF5 (SEQ ID NO:5), the thymidine kinase gene, and the intergenic region corresponding to genes coding for the large subunit and the small subunit. Immunological or vaccine compositions as well as methods for inducing an immunological response are also disclosed and claimed.
    Type: Application
    Filed: September 7, 2004
    Publication date: February 2, 2006
    Inventors: Jean-Christophe Audonnet, Philippe Baudu
  • Patent number: 6818628
    Abstract: Disclosed and claimed are compositions for inducing in a bovine host an immunological response against bovine respiratory syncytial virus or bovine viral diarrhea virus containing at least one plasmid that contains and expresses in vivo in a bovine host cell nucleic acid molecule(s) having sequence(s) encoding bovine respiratory syncytial virus F protein, or G protein, or F and G proteins; or, at least one plasmid that contains and expresses in vivo in a bovine host cell nucleic acid molecule(s) having sequence(s) encoding bovine viral diarrhea virus E2 protein, or C, E1 and E2 proteins, or E1 and E2 proteins. Methods and kits employing such compositions are also disclosed.
    Type: Grant
    Filed: February 28, 2002
    Date of Patent: November 16, 2004
    Assignee: Merial
    Inventors: Jean-Christophe Audonnet, Annabelle Bouchardon, Philippe Baudu, Michel Riviere
  • Patent number: 6576243
    Abstract: Disclosed and claimed is: an immunogenic or vaccine composition for inducing in an avian host an immunological response against avian pathologies containing at least one plasmid that contains and expresses in vivo in an avian host cell nucleic acid molecule(s) having sequence(s) encoding antigen(s) of the avian pathogen(s); and, methods for using and kits employing such compositions.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: June 10, 2003
    Assignee: Merial
    Inventors: Jean-Christophe Audonnet, Annabelle Bouchardon, Philippe Baudu, Michel Riviere
  • Publication number: 20030017172
    Abstract: Disclosed are plasmids that contain and express in vivo in a feline host cell nucleic acid molecules. The plasmid can include nucleic molecule(s) having sequence(s) encoding infectious peritonitis virus M; feline immunodeficiency virus env, or gag, or pro, or gag and pro, or env and gag and pro; rabies G; or feline leukemia virus env and/or gag. Compositions containing such plasmids, methods of use employing such plasmids, and kits involving such plasmids, are also disclosed.
    Type: Application
    Filed: August 30, 2001
    Publication date: January 23, 2003
    Inventors: Jean-Christophe Audonnet, Annabelle Bouchardon, Philippe Baudu, Michel Riviere
  • Publication number: 20030003112
    Abstract: What is described is a recombinant vector, such as a virus; for instance, a poxvirus, such as avipox virus, containing foreign DNA from porcine reproductive and respiratory syndrome virus. What are also described are immunological compositions containing the recombinant poxvirus for inducing an immunological response in a host animal to which the immunological composition is administered. Also described are methods of treating or preventing disease caused by porcine reproductive and respiratory syndrome virus by administering the immunological compositions of the invention to an animal in need of treatment or susceptible to infection by porcine reproductive and respiratory syndrome virus.
    Type: Application
    Filed: May 21, 2001
    Publication date: January 2, 2003
    Inventors: Jean-Christophe Audonnet, Michel Bublot, Jennifer Perez, Philippe Baudu
  • Publication number: 20020160018
    Abstract: Disclosed and claimed are compositions for inducing in a bovine host an immunological response against bovine respiratory syncytial virus or bovine viral diarrhea virus containing at least one plasmid that contains and expresses in vivo in a bovine host cell nucleic acid molecule(s) having sequence(s) encoding bovine respiratory syncytial virus F protein, or G protein, or F and G proteins; or, at least one plasmid that contains and expresses in vivo in a bovine host cell nucleic acid molecule(s) having sequence(s) encoding bovine viral diarrhea virus E2 protein, or C, E1 and E2 proteins, or E1 and E2 proteins. Methods and kits employing such compositions are also disclosed.
    Type: Application
    Filed: February 28, 2002
    Publication date: October 31, 2002
    Inventors: Jean-Christophe Audonnet, Annabelle Bouchardon, Philippe Baudu, Michel Riviere
  • Patent number: 6376473
    Abstract: Disclosed and claimed are compositions for inducing in a bovine host an immunological response against bovine respiratory syncytial virus or bovine viral diarrhea virus containing at least one plasmid that contains and expresses in vivo in a bovine host cell nucleic acid molecule(s) having sequence(s) encoding bovine respiratory syncytial virus F protein, or G protein, or F and G proteins; or, at least one plasmid that contains and expresses in vivo in a bovine host cell nucleic acid molecule(s) having sequence(s) encoding bovine viral diarrhea virus E2 protein, or C, E1 and E2 proteins, or E1 and E2 proteins. Methods and kits employing such compositions are also disclosed.
    Type: Grant
    Filed: January 15, 1999
    Date of Patent: April 23, 2002
    Assignee: Merial
    Inventors: Jean-Christophe Audonnet, Annabelle Bouchardon, Philippe Baudu, Michel Riviere
  • Patent number: 6348196
    Abstract: Disclosed are plasmids that contain and express in vivo in a feline host cell nucleic acid molecules. The plasmid can include nucleic molecule(s) having sequence(s) encoding infectious peritonitis virus M; feline immunodeficiency virus env, or gag, or pro, or gag and pro, or env and gag and pro; rabies G; or feline leukemia virus env and/or gag. Compositions containing such plasmids, methods of use employing such plasmids, and kits involving such plasmids, are also disclosed.
    Type: Grant
    Filed: January 15, 1999
    Date of Patent: February 19, 2002
    Assignee: Merial
    Inventors: Jean-Christophe Audonnet, Annabelle Bouchardon, Philippe Baudu, Michel Riviere
  • Patent number: 6207165
    Abstract: The present invention relates to a vaccine formula allowing in particular the vaccination of pigs against reproductive and respiratory pathologies. It also relates to a corresponding method of vaccination.
    Type: Grant
    Filed: January 15, 1999
    Date of Patent: March 27, 2001
    Assignee: Merial
    Inventors: Jean-Christophe Audonnet, Annabelle Bouchardon, Philippe Baudu, Michel Riviere
  • Patent number: 6159477
    Abstract: Disclosed and claimed is a recombinant canine herepes virus (CHV). The recombinant CHV includes and expresses at least one heterologous nucleotide sequence encoding an antigen. The antigen can be canine distemper virus HA, canine distemper virus F, rabies virus G, canine parvovirus VP2, parainfluenza virus type 2 HA, parainfluenza virus type 2 F, Borrelia burgdorferi OspA, or Borrelia burgdorferi OspB. The at least one heterologous nucleotide sequence can be in at least one insertion site selected from the group consisting of ORF3 (SEQ ID NO:4), ORF5 (SEQ ID NO:5), the thymidine kinase gene, and the intergenic region corresponding to genes coding for the large subunit and the small subunit. Immunological or vaccine compositions as well as methods for inducing an immunological response are also disclosed and claimed.
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: December 12, 2000
    Assignee: Merial
    Inventors: Jean-Christophe Audonnet, Philippe Baudu